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Abstract
Background: Magnetic resonance imaging (MRI) phantoms are routinely used for quality assurance in MRI centres;
however their long term stability for verification of myocardial T1/ extracellular volume fraction (ECV) mapping has
never been investigated.
Methods: Nickel-chloride agarose gel phantoms were formulated in a reproducible laboratory procedure to mimic
blood and myocardial T1 and T2 values, native and late after Gadolinium administration as used in T1/ECV
mapping. The phantoms were imaged weekly with an 11 heart beat MOLLI sequence for T1 and long TR spin-echo
sequences for T2, in a carefully controlled reproducible manner for 12 months.
Results: There were only small relative changes seen in all the native and post gadolinium T1 values (up to 9.0 %
maximal relative change in T1 values) or phantom ECV (up to 8.3 % maximal relative change of ECV, up to 2.2 %
maximal absolute change in ECV) during this period. All native and post gadolinium T2 values remained stable over
time with <2 % change.
Temperature sensitivity testing showed MOLLI T1 values in the long T1 phantoms increasing by 23.9 ms per degree
increase and short T1 phantoms increasing by 0.3 ms per degree increase. There was a small absolute increase in
ECV of 0.069 % (~0.22 % relative increase in ECV) per degree increase.
Variation in heart rate testing showed a 0.13 % absolute increase in ECV (~0.45 % relative increase in ECV) per 10
heart rate increase.
Conclusions: These are the first phantoms reported in the literature modeling T1 and T2 values for blood and
myocardium specifically for the T1mapping/ECV mapping application, with stability tested rigorously over a
12 month period. This work has significant implications for the utility of such phantoms in improving the accuracy
of serial scans for myocardial tissue characterisation by T1 mapping methods and in multicentre work.
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Background
Over the last few decades, cardiovascular magnetic res-
onance has emerged as an important imaging modality
in clinical cardiology and research. However, to ensure
accurate results, magnetic resonance imaging (MRI)
phantoms have become essential in the development
and adjustment of MRI systems as well as maintenance
and further evaluation of performance. The recent ad-
vent and popularity of MRI based parametric mapping
techniques [1] has enabled significant opportunity for
enhanced myocardial tissue characterisation. Myocardial
T1 mapping methods provide a robust technique [2] fre-
quently used both clinically and in research across a
wide spectrum of cardiac conditions including cardiac
infiltration [3, 4, 5], inflammation [6, 7], coronary artery
disease [8, 9] and siderosis [10]. However, they are well
known to be potentially biased [1, 11] to a degree that
can depend on protocol parameters, sequence and re-
construction used, with many hidden parameters that
are difficult to hold constant over long periods over sys-
tem upgrades and especially unlikely to be replicated
precisely between different models of scanners. There-
fore, phantoms have been recommended for Quality As-
surance (QA) [11, 12] to provide adequate quality control
and protection against scheduled or unplanned changes
or failures in the MRI system, control for longitudinal
(long-term over time) stability and potentially assist cali-
bration between values obtained from multicentre work.
The usefulness of the phantoms lies in their unique ability
to provide reassurance against such changes during a
research project or in support of clinical applications,
and provide basic data that could enable correction across
such a change if it were to occur. However phantom-
based quality assurance has not been undertaken robustly
over a long-term period for T1 mapping sequences.
Previous work on MRI phantoms succeeded in cor-
rectly reproducing T1 and T2 values [13, 14, 15], how-
ever, their life expectancy was mainly maintained over
only a short period of time [16, 17].
The aims of this study were to:
(1) Identify whether blood and myocardial T1 and T2
values in the human range before and late-after
administration of gadolinium-based contrast agent
(“Gadolinium, Gd”) could be reproduced in
phantoms, allowing a model for test values into a
phantom extracellular volume fraction (ECV)
calculation as part of the QA,
(2) Identify whether the phantoms could provide
sufficient longitudinal stability over a 12 month period
of T1 mapping assessment, enabling them to act as a
controls against technical changes, planned or
unexpected changes/ upgrades in the MRI system,
that could impact on T1 and ECV measurements, and
(3) Assess the variation of temperature and heart rate
on the T1 values measured.
The assessment of variation with temperature and
heart rate (HR) could enable investigation of re-
calibration requirements both when used in vivo, e.g.
when scanning patients at extreme heart rates, but also
in vitro when using phantoms for temporal calibration
of a single MRI system but also importantly across mul-
ticentre work, where confirmation of consistent T1 bias
might be required, or if different provide a means to cor-
rect data between the centres. Caution should be used
however when considering T1 adjustments for variation
in temperature in vivo. Although one would expect only
small temperature variation in humans due to the body’s
own thermoregulatory control; ex vivo work has shown
that the relaxivity of Gd-complexes are temperature
dependent [18], therefore one would not be able to ac-
curately predict the Gd in vivo response to temperature
using work with Nickel based phantoms.
Calibration of T1 values across many centres would
also not be an easy task as all the phantoms need to be
scanned at the reference centre (centre 1) with one se-
quence, transferred safely to the new centre (centre 2)
for regular scanning with potentially a different sequence
and vendor and then returned to centre 1 for repeat
scanning to ensure that there was no drift in the phan-
toms during transportation. Using values from both cen-
tres a specific correction algorithm will then need to be
developed. This can become even more complex if two
or more additional centres are utilising the same set of
phantoms. Additionally, for this work, it was necessary
to model both T1 and T2 values for each tissue because
T2 can cause bias in the estimation of T1 by the single-
breath-hold methods used in cardiac MRI, hence the
weekly scans included T2 measurements to investigate
whether any potential drifts seen in T1 relaxation times
occurred as a result of changes in T2 times.
Methods
Phantom materials and recipe
Published T1 values were referenced [19] to create
phantoms with targeted T1 values at 1.5 T and 37 °C of:
(1) native myocardial T1 1000 ms, T2 50 ms;
(2) native blood T1 1450 ms, T2 250 ms;
(3) post-Gd myocardial T1 500 ms, T2 45 ms; and
(4) post-Gd blood T1 380 ms, T2 140 ms.
Nickel-chloride (NiCl2) agarose gel phantoms were
made by a reproducible laboratory procedure, calculated
to model the above T1 and T2 values. Nickel doped gels
were chosen to vary proton T1 rates, whilst T2 rates
were determined by the concentration of agarose used
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as the gelling agent [14, 15]. Other paramagnetic ions
were avoided because of their known larger temperature
dependence than Nickel [14].
NiCl2 (Nickel (II) chloride hexahydrate 99.9999 %,
ACROS Organics ™) stock solutions at 1 mM, 3 mM and
6 mM were made for accuracy and stored refrigerated in
sealed 1 or 2 L flasks. For preparation of these stock so-
lutions large measuring flasks were used with a 1 or 2 L
line on the neck. After its initial opening, the appropri-
ate NiCl2 weight was transferred onto a plastic boat and
was washed into the flask with de-ionised water. This
process was achieved rapidly as NiCl2.6H2O is highly
hygroscopic, and once opened the NiCl2 hexahydrate
(supplied under a dried atmosphere) could not accur-
ately be reused. The flask was topped up with distilled
water, with frequent stops and mixing to form the
chosen stock for storage. The preparation was per-
formed at room temperature and no heating was neces-
sary as this compound is easily soluble.
For each required phantom, a conical flask holding
150 ml allowing fast stirring was taken and placed on a
chemical balance and its weight was zeroed. The
prescribed weight (see below) of agarose (Agarose low
EEO for electrophoresis, Mr ≤ 0.07, ACROS Organics ™,
nutrient-free) powder was added to the flask. The neces-
sary volumes of the appropriate stock solution and dis-
tilled water were added to titrate up to 150 ml total
volume. The 150 ml mixture was made as a deliberately
large volume to minimise the impact of agar powder
weighing and 1 ml fluid measurement errors. For even
more accurate results, ideally an even larger mass-
production volume could be used. This was achieved by
aiming for 1 ml precision of use of the measuring cylin-
ders, using pipettes to assist this process. In this way,
agarose, stock solution and distilled water were mixed in
specified quantities to derive the selected T1 and T2
values. The specified mixtures were brought near to the
boiling-point using a microwave oven until the agarose
completely dissolved and a transparent solution was ob-
tained. Excessive boiling was not permitted for fear of
losing some of the water content, which would in effect
concentrate each mixture inadvertently by an unknown
amount. Regular stirring was required to ensure uni-
formity of the mixture during the agar-dissolution
process as the fluid is colourless. In early trial prepara-
tions, it was noted that the lack of regular stirring re-
sulted in a non-uniform agarose composition that had to
be discarded. The solutions were then carefully trans-
ferred into 60 ml glass narrow-neck sealed thick-wall
bottles (Fisherbrand ™ Clear Soda Lime Glass Boston
Round Narrow Mouth Bottles with Polyvinyl Cap), for
minimal vessel permeability and to reduce area of poten-
tial contact with air (Fig. 1), filled with minimal gaps
resulting from gel contraction while cooling. Two 60 ml
bottles were filled from each 150 ml batch. In order to
minimise potential B0 distortions in the gel, caution
was applied to ensure that any air bubbles were ap-
propriately released from the gel. Failure to do so
could have caused the bubbles to become trapped in
the solidified gel, leading to increased B0 distortion in
the gel around such gaps and making it unacceptable
for MRI use; as well as leading to difficulty in draw-
ing regions of interest (ROI) during post-processing
to obtain correct T1 values.
Particular care was taken to minimise air entrapment
and formation of cracks through cooling of the phantoms
as follows:
 Agar sets on cooling at around 45 °C whereas to
dissolve it takes at least 95 °C; this hysteresis is well
Fig. 1 Title: A 60mls narrow neck bottle used. Legend: The 60mls
narrow-neck bottles used (Fisherbrand TM Clear Soda Lime Glass
Boston Round Narrow Mouth Bottles with Polyvinyl Cap) to minimise
gel-to-environment exposure by reducing the contact surface area.
These were considered more likely to deliver stability than thin-wall
tubes with poorly-fitting broad caps
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known [20]. On setting, the fluid contracts to form
the solid gel. Controlling the setting process in the
60 ml tubes was important to avoid crack formation
which could invalidate use of the tubes as MRI
phantoms.
 After pouring in the hot gel fluid, the tubes were
stood in approximately 1 cm tall cold water bath to
cause gel setting from the base upward, so that the
contraction of the cooling gel pulled the contents
downward, leaving a gap at the top of the phantom.
 Cold water was added to this bath during setting
which was visible as white cloudiness in the set gel
beginning at the base. This gap was “topped up”
with more gel allowed to set until the phantom was
filled and the cap screwed on.
As observed from our earlier phases, failure to under-
stand and follow this procedure caused the gel to set be-
side the vertical walls of the bottle and formation of a
large contraction gap down the middle of the bottle ren-
dering it unusable for MRI.
Upon completion of cooling, the phantoms were im-
aged as described fully later in the methods section,
using Siemens 448B Prototype 11 heart beat Modified
Look-Locker inversion recovery (MOLLI) for T1 map-
ping and with long TR (4.5 s) spin-echo sequences for
T2 mapping. Multiple iterations of the phantoms were
subsequently trialled with adjustments of reagent
concentrations, eventually settling on formulations for
the targeted T1 and T2 values as tabulated below
(Table 1).
The composition of the 150 ml conical flask contents
for these phantoms was obtained by combining:
(A) 0.9 mM Ni2+ 2.10 % 3.150 g agarose, 1 mM stock
0.9x150/1 = 135 ml, adding 15 ml water.
(B) 0.48 mM Ni2+ 0.45 % 0.675 g agarose, 1 mM stock
0.48x150/1 = 72 ml, adding 78 ml wate.r
(C) 2.35 mM Ni2+ 2.50 % 3.750 g agarose, 3 mM stock
2.35x150/3 = 117.5 m, adding 32.5 ml water.
(D) 3.7 mM Ni2+ 0.45 % 0.675 g agarose, 6 mM stock
3.7x150/6 = 92.5 ml, adding 57.5 ml water.
The phantoms were observed weekly for evidence of
mould growth or cracks in the gel.
Phantom imaging
The tubes were glued inside a plastic box for protection
but no other fill was placed in this outer box. The box
contained 8 tubes (two for each mixture A, B, C, D) in a
4x2 grid with 1.5 cm airgaps between the tube outer
walls. For imaging, the long axis of each phantom tube
was aligned with the z axis of the scanner. Two MRI cy-
lindrical test bottles (diameter 12 cm, height 20 cm, vol-
ume 2 L) were placed on each side to support the MRI
system (MAGNETOM Avanto, Siemens Healthcare, Er-
langen, Germany) calibrations of reference frequency
and B1 field, and a transverse slice midway along the 8
tubes within it was imaged following localisers. The ad-
justment volume, 20 cm x, 12 cm y and 2 cm z, was
used to set only the scanner reference frequency because
the preset first- and second-order shim settings (known
as “Tune-Up” based on a 30 cm-diameter spherical
phantom at isocentre) were used without specific adjust-
ment (“shimming”) of these for the T1 mapping
phantom.
The phantoms were kept in the same MRI room with
a temperature logger, and imaged weekly for 1 year using
consistent coil and phantom support arrangements, with
the identical sequence version and parameters each
week. The image parameters were the same subject to
automatic calibrations of flip angle and reference fre-
quency using an identical adjustment volume each week:
1. For T1, MOLLI FOV 360 ×306 mm, slice thickness
8 mm, flip angle 35°, parallel imaging with
acceleration factor 2 was used at high-resolution
(256 independent pixels over 360 mm and 144 over
306 mm (acquiring 126 by 7/8th partial ky), TR/TE
2.6/1.1 ms, single-shot image acquisition duration
194 ms) at an electronically programmed heart rate
of 75 bpm; and low-resolution (192 independent
pixels over 360 mm and 128 over 306 mm (acquir-
ing 112 by 7/8th partial ky), TR/TE 2.4/1.0 ms,
single-shot image acquisition duration 159 ms) at an
electronically programmed heart rate of 100 bpm)
versions, with pre-contrast 5(3)3 and post-contrast
4(1)3(1)2 variants. The use of different variations of
the MOLLI sequence for the native and post-Gd
values has been adopted in line with Schelbert et al.
[21] as the two different variations allow better opti-
misation of images with long and short T1 respect-
ively. This was unlikely to have influenced the
longitudinal results as the 5(3)3 sequence was always
Table 1 Final relative concentrations of Nickel ion (Ni2+) and
Agarose required to mimic native and late-Gd human blood
and myocardium T1 and T2 values
Nickel (mM) Agarose (%) T1 (ms) T2 (ms)
Mixture A
Native Myocardium
0.90 2.10 1000 55
Mixture B
Native Blood
0.48 0.45 1500 225
Mixture C
Post-Gd Myocardium
2.35 2.50 510 44
Mixture D
Post-Gd Blood
3.70 0.45 365 125
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used for imaging and comparison of the native
values and the 4(1)3(1)2 for the post-Gd values.
2. For T2, spin-echo imaging FOV 230 × 108 mm, slice
thickness 10 mm, TR/TE 4500/22-264 ms, flip angle
180°.
Mean T1 and T2 values were taken in ROIs on pixel-
wise maps, examined for drift and analysed on a
dedicated software package (CMR Tools, Cardiovascular
imaging solutions, London, UK; Fig. 2). The coefficient
of variation (CoV = 100× standard deviation/mean) % of
52 weeks was compared against 10 re-positioned repeats
acquired within 2 h.
Using the individual components for native and post-
Gd blood and myocardium and assuming a “phantom
haematocrit” of 0.425 we could calculate a test “extracel-
lular volume fraction” (ECV) of the phantom for assess-
ment of drift impact using the equation:
ECV ¼ 1−haematocritð Þ
1
T1myopost
−
1
T1myopre
 
—————————————————
1
T1 blood post
−
1
T1 blood pre
 
The temperature was measured continuously during the
first 6 months using an MR-safe digital thermometer
placed on top of the phantom box (during storage, not
scanning) to the nearest 0.5 °C. For the remaining
6 months manual read-outs were made from a liquid crys-
tal thermometer strip glued on top of the phantom box at
each weekly time scan to the closest 0.5 °C and recorded.
The T1 results are reported first as measured and second
with application of a temperature-correction to take into
consideration the small temperature variation each week.
The temperature correction parameters are based on the
results of the temperature experiments described below.
There is no standardised method of reporting changes
in phantom values, so we calculated the overall change
in phantom T1 in two ways, ensuring that we did not
underestimate the effect: Firstly, the phantoms were
scanned weekly for a year obtaining 52 values per phan-
tom. Four successive weekly values per phantom were
averaged resulting in 13 independent values per phan-
tom. The difference between the highest and the lowest
value divided by the highest value was calculated as the
percentage change. Secondly, the first 4 values and last 4
values were averaged and their difference was divided by
the highest value.
Variation in temperature assessment
The effect of variation in temperature on T1 was
examined using four separate phantoms with T1 values
at 25 °C of 1915, 1040, 530, 280 ms broadly similar to
native blood, native myocardium, post-Gd myocardium
and post-Gd blood values respectively. A water bath was
prepared and the phantoms were immersed and the
temperature was manually read using a mercury therm-
ometer to the nearest 0.2 °C (Fig. 3). We started at a
temperature of 35 °C cooling down using cold water and
finely crushed ice to 15 °C, ensuring careful mixing of
the water even after complete melting of the ice to allow
a homogeneous temperature whilst imaging at steady
HR with real-time reporting of the T1 values. The phan-
toms used for the temperature experiment were not
used in any further longitudinal follow up to avoid any
long lasting effect of extreme temperatures on the gels.
Fig. 2 Title: Post processing T1 and T2 images. Each phantom mixture was included twice giving a total of four different mixtures. Legend: Panel
a is the original inversion recovery image, panel b is the spin echo magnitude image. Panels c and d represent the final maps; panel C is the T1
map and panel D is the T2 map. The ROI mean values were taken well within the phantoms away from edge-ringing artefacts such as Gibbs
artefact [26] using CMR Tools
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Of note is the orientation of these phantoms vertically
across B0 would not normally be used in air due to B0
distortion effects, but the fluid fill in the box smoothed
these out within the central region occupied by the four
tubes. This orientation differed from the setup described
above for the weekly drift-assessment scans, although
the two side bottles were still placed next to the outer
box.
Variation in heart rate assessment
The effect of variation in HR on T1 was also assessed
using phantoms with the same values as in Table 1. They
were imaged at low resolution (HR > 90 bpm) and high
resolution (<90 bpm) for RR 1400-490 ms representing
HR 43–122 bpm and at steady temperature, but the ini-
tial HR scan was repeated at the end of each series to
guard against any unforeseen drift effects.
Results
Longitudinal stability of phantom T1 without temperature
correction
Both high resolution and low resolution sequences gave
similar T1 means, standard deviation and coefficient of
variation (CoV) for blood and myocardium native and
post-gadolinium (Table 2).
The CoV was higher for the longer T1 and longer T2
values. Specifically for the T1 values, there was no sig-
nificant drift seen in the shorter T1 values (native myo-
cardium and post-gad blood and myocardium) but there
was an increase in the longer native blood value over the
1 year as shown in Table 3 and Fig. 4.
Longitudinal stability of phantom T1 with temperature
correction
When adjusting for the small temperature variations
(temperature mean = 21.6 ± 0.9 °C, range 19.5–23 °C)
using results from the temperature variation part of the
experiment (see below) the results obtained are shown
in Fig. 5.
Long-term temporal variation of T1
The results of phantom T1 change over 12 months are
shown in Table 3. Although not the aim of this work, all
T2 parameters remained stable with relative <2 % over
the 12 month period.
Effect of temperature change on T1 values
The phantoms were also used to determine the effect of
temperature on T1 values. With increase in temperature
the very long (similar to pre-Gd blood) and long T1
(similar to pre-Gd myocardium) appeared to increase:
Tube A Native bloodð Þ ¼ 23:86  Temp þ 1323:3 ms;
R2 ¼ 0:99; p < 0:0001 and
Fig. 3 Title: The phantom arrangement during the water bath.
Legend: Image showing the phantoms in the water bath, the
mercury thermometer (arrow) stabilised in the water bath and the
preparation inside the MRI scanner
Table 2 Showing the variation during a 52 week period of the Phantom unadjusted T1 and T2 values and ECV using an 11-cycle 8-
image MOLLI native (pre-Gd) 5(3)3 and post-Gd 4(1)3(1)2. Two phantoms for each T1 and T2 mixture were installed in the box. The value
used for analysis represents the average of the two. The phantom ECV was calculated from the myocardial and blood native and
post-Gd phantom T1 values using a haematocrit of 0.425. This was a chosen value representing a typical adult human haematocrit
T1 T2
Mean (ms) SD CoV (%) Mean (ms) SD CoV (%) Mean (ms) SD CoV (%)
High resolution (75 bpm) Low resolution (100 bpm) Spin-echo protocol
Native myocardium 971.8 12.6 1.3 971.8 13.6 1.4 56 1.3 2.2
Native blood 1578.8 56.4 3.6 1549.8 61.9 4.0 234 8.0 3.4
Post Gd myocardium 498.3 5.1 1.0 497.6 13.5 1.4 48 0.9 1.9
Post Gd blood 371.9 6.4 1.7 371.8 6.5 1.8 149 3.0 2.0
ECV 27.4 % 0.9 3.2 27.6 % 0.9 3.1
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Tube B Native Myocardiumð Þ ¼ 6:27  Temp þ 883 ms;
R2 ¼ 0:98; p < 0:0001:
The shorter T1 values similar to post-Gd myocardium
and blood showed only a small association with
temperature changes. These followed the equations:
Tube C post−Gd myocardiumð Þ ¼ 0:27 X Temp þ 525 ms;
R2 ¼ 0:24; p ¼ 0:02;
and the
Tube D post−Gd bloodð Þ ¼ 0:81  Temp þ 304 ms;
R2 ¼ 0:71; p < 0:001Þ
as shown in Fig. 6.
Putting these changes in the ECV calculator we can
see that the increase in ECV would be in the region of
0.1–0.3 ECV units for each degree increase.
An example of incorporating these changes in the
ECV calculator is shown below, we can identify the
change in ECV per each one degree C difference in
temperature.
ECV ¼ 1−haematocritð Þ
1
T1myopost
−
1
T1myopre
 
—————————————————
1
T1 blood post
−
1
T1 blood pre
 
For example assuming that the following values were
obtained at temperature X°C, the ECV would corres-
pond to:
ECV at temperatureX∘C ¼ 1−0:425ð Þ 
1
500
−
1
1000
 
————————
1
400
−
1
1500
 
Giving an ECV at X°C = 31.36 %.
However, at X + 1 °C using our average change in
values for native and post-Gd blood and myocardium
the following changes would be expected:
Native blood +23.86 ms, native myocardium
+6.27 ms, post-Gd myocardium +0.27 ms, post-Gd blood
+0.81 ms.
Putting these new values in the ECV calculator we can
calculate the following ECV for temperature X + 1 °C:
ECV at temperatureX∘C ¼ 1−0:425ð Þ 
1
500:27
−
1
1006:27
 
———————————
1
400:81
−
1
1523:86
 
Giving an ECV at temperature X + 1 = 31.43 %.
This represents an absolute change in ECV of 0.069 %
or a relative change in ECV of ~0.22 % per one degree C
change in temperature.
Effect of heart rate variation on T1 values
Using the phantoms prepared, the effect of variation in
HR was also assessed. There was a small but definite in-
crease in ECV with increase in HR as shown in Fig. 7.
This followed a linear relationship:
ECV ¼ 0:013  HR þ 28; R2 ¼ 0:85; p < 0:0001
Using the phantoms prepared, the effect of HR vari-
ation was also assessed. There was a small but definite
increase in ECV with increase in HR as shown in Fig. 7.
This followed a linear relationship:
ECV ¼ 0:013  HR þ 28; R2 ¼ 0:85; p < 0:0001
For example at 50 bpm the ECV is expected to be:
ECV at 50bpm ¼ 0:013  50 þ 28 ¼ 28:65 %
Whilst at 60 bpm it is expected to be:
ECV at 60bpm ¼ 0:013  60 þ 28 ¼ 28:78 %
suggesting a small absolute increase in ECV of 0.13 %
for every 10 bpm increase in heart rate, relative increase
in ECV of ~0.45 %.
However, this change in ECV appears to be driven pre-
dominantly by a change in native blood T1 (Native
blood T1 = −0.78 X HR + 1700, R2 = 0.90 p < 0.0001) as
shown in Fig. 8. As such, if patients with extreme heart
rates need to be scanned, native myocardial T1 (Fig. 8),
might be more accurate as this showed no significant
variation with changes in HR (T1 native myocardium =
0.017 × HR + 981, R2 = 0.02, p = 0.499).
The change in ECV observed with varying heartrate was
small; however it appears to relate mainly to a change seen
in the native blood values. The remaining values modeling
native myocardium, post-Gd blood and post-Gd myocar-
dium appear less sensitive to changes in HR.
Table 3 Showing the overall relative changes in the various T1
parameters over a 12 month period. Independently of method
used, all the parameters showed a change of <10 %
Method 1 (%) Method 2 (%)
Native blood / ms 9.0 7.8
Native myocardium / ms 3.6 0.5
Post Gd myocardium / ms 2.9 1.9
Post Gd blood / ms 5.0 3.5
ECV / % 8.3 5.3
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Fig. 4 (See legend on next page.)
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Discussion
Longitudinal stability of phantoms
We have observed that the change in T1 values observed
over a 12 month period was small. This would support
that phantoms based on the recipe and construction
process we have described could be utilised to provide
quality assurance for at least 12 months.
However, this conclusion depends on the exact appli-
cation of T1 or ECV mapping being monitored. The
native myocardial phantom appeared stable whereas the
relatively large change in native blood phantom rendered
the phantom ECV change from 27.0 to 28.5 % during
the year, making phantoms potentially less useful for ap-
plications such where ECV is used for assessment of
possible subclinical early and small changes in diffuse fi-
brosis for example. Appreciating that a difference of 3 %
in absolute ECV values is associated with significantly
worse short-term prognosis [22, 23] and contextualising
(See figure on previous page.)
Fig. 4 Title: Longitudinal imaging for T1 values and variation in temperature. Legend: Panel a longitudinal stability without temperature
correction for native and post contrast myocardial and blood phantom T1 values. The phantoms corresponding to native blood T1 values
showed a slow drift, whist the remaining phantoms corresponding to native myocardium and post-contrast blood and myocardium remained
relatively stable. Panel b weekly temperature variation of the MRI room. Panel c fusing the individual variables from panel a , and a haematocrit
of 0.425 a Phantom ECV was calculated
Fig. 5 Title: Temperature adjusted T1 values. Legend: Longitudinal follow-up showing adjusted values for T1 (panel a) and ECV (panel b) incorporating
the small temperature variation. The overall results however, of a small drift in the native blood T1 phantoms remained unchanged
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the drift noticed, we would argue that it is advisable to
undertake regular scanning of the phantoms (at least
monthly, based on our results) in all units undertaking
T1 mapping rather than only opportunistic scanning be-
fore any major upgrades, as such an approach could in-
correctly estimate the true adjustment required to the
ECV values.
Discrepancies arise over the longevity of these agar-
based phantoms. Contamination and mould growth, un-
like other gels containing nutrients was not seen to
occur in any of approximately 100 tubes made on differ-
ent occasions during this work using nutrient-free agar-
ose, and it is also possible the Ni2+ ions also contribute
to growth prevention [24], even though complete sterile
conditions were not used for manufacture. The instabil-
ity of gels even if sealed properly inside a tube arises
from the contraction of the gel as it dries out. It can do
so even within a sealed tube, depositing the water as
droplets on the inside of the tube, in the gap left by the
contracting gel. The rate at which this occurs is quite
uncertain depending on tube and cap design which may
allow some water to dry out of the tube, but the effect
has still often been noted in well-sealed tubes.
Variation in temperature and phantom T1
Variation in temperature produced only small changes
on the T1 values modeling close to the native and
post-Gd myocardium and blood. However, the largest
difference was seen on the T1 closer to native blood
showing a change of almost 24 ms per 1 °C variation.
Importantly, the variation in temperature required to
make any of these small changes clinically significant
will be very large and is outside the range of
temperature changes expected to be seen in clinical
practice in the heart.
Nonetheless, this confirms that for quality assurance
across different vendors and sites the phantoms should
ideally be imaged in a temperature-controlled environ-
ment with minimal changes (<5 °C) and if this is not
possible to record and compensate the values accordingly
Fig. 6 Title: T1 variation with temperature. Legend: Effect of temperature variation on native and post-Gd myocardial and blood T1. This
effect appears to predominantly affect the longer T1 values
Fig. 7 Title: ECV change with heart rate variation. Legend: Graph demonstrating the linear relationship of between HR change and change in
ECV. This change was overall small with a 0.13 % absolute increase per 10 heart beat increase
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using a correction equation derived from temperature
data on the phantoms. Likewise, for comparison of multi-
centre work in the absence of a correction equation, statis-
tical comparison could be undertaken by employing
for example regression analysis using a mixed effects
model to assess the impact of systematic inter-centre
differences.
Variation in heart rate and phantom T1
Furthermore, using the phantoms prepared we investi-
gated the effect of HR variation on T1 values. We identi-
fied that ECV change was small, estimated at 0.13 ECV
units for every increase in 10 bpm. As this difference is
small, it suggests that it is unlikely to be relevant for pa-
tients in clinical practice unless imaged in decompen-
sated states (e.g. uncontrolled heart failure, fast atrial
fibrillation). In such a situation, native myocardial T1
might be a more appropriate parameter to use as it was
the most stable with variation in HR, with every 10 bpm
increase changing the T1 by 0.17 ms and therefore,
might be a more reliable parameter to use when imaging
patients at extreme heart rates. This work also supports,
that for quality assurance the same HR should be used
for longitudinal assessment and also for calibration pur-
poses across various vendors, sites and T1 mapping
sequences.
Study limitations
Firstly, this is a single centre study where phantoms were
prepared and imaged in the same institution, therefore did
not have to undergo any transport which could have al-
tered their parameters and long term survival. As such,
the true usefulness of MRI phantoms in multicenter work
can only be assessed once tested in the various centres.
Furthermore, the phantoms were prepared in a clinically
licensed biochemistry laboratory under standard and re-
producible conditions, but sterile conditions were not
used. Nonetheless, at 12 months there was no evidence of
mould growth or inaccuracies relating to contamination.
Neither accuracy data nor magnetisation transfer was
assessed, as this experiment focused on long-term preci-
sion. Finally, part of the variation noted when HR was
tested is because the time allowed for recovery in MOLLI
protocols used is applied as counted heartbeats. The dur-
ation of this recovery gap therefore varies with HR, likely
introducing more error for tubes with longer T1 values
that do not recover fully in this time. A modification to
MOLLI has been proposed which enforces this gap as
a minimum number of seconds not in counted heart-
beats [25]. The possible impact of this modified
method on the small change seen in the longest T1
tube was not tested in this study.
Conclusion
We have shown for the first time that Nickel-based
phantoms can serve for quality-control over a 12 month
period with small changes in native and post-Gd myo-
cardial and blood values and ECV as assessed by an 11
heart beat MOLLI. However, their utility probably re-
quires at least monthly rescanning against phantom
drift, to provide some index for correction in the event
of a scanner upgrade or modification requiring this.
These results should encourage routine use to support
both clinical and research activities using MOLLI
sequences.
Fig. 8 Title: Change in T1 values with heart rate variation. Legend: The effect of heart rate variation in phantoms modeling native and post-Gd
myocardium and blood
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